Personalis (PSNL) Cash from Financing Activities (2018 - 2026)
Personalis (PSNL) recorded quarterly Cash from Financing Activities of $17.8 million in Q1 2026, down 83.92% quarter-over-quarter from $110.9 million in Q4 2025, and down 11.24% on a YoY basis from $20.1 million in Q1 2025.
Personalis (PSNL) Cash from Financing Activities (2018 - 2026) Analysis & Trends
Personalis' Cash from Financing Activities history runs 9 years deep, the most recent figure standing at $17.8 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 11.24% year-over-year to $17.8 million; the TTM figure through Mar 2026 stood at $128.1 million (down 4.15% YoY), while the FY2025 annual figure was $130.3 million, up 13.66% from the prior year.
- Cash from Financing Activities was $17.8 million for Q1 2026 at Personalis, down from $110.9 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $110.9 million in Q4 2025 to a low of -$420000.0 in Q2 2022.
- Historically, Cash from Financing Activities has averaged $18.3 million across 5 years, with a median of $1.1 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities soared 21426.21% in 2024, then tumbled 121.57% in 2025.
- A 5-year view of Cash from Financing Activities shows it stood at $511000.0 in 2022, then soared by 1820.94% to $9.8 million in 2023, then jumped by 405.31% to $49.6 million in 2024, then surged by 123.57% to $110.9 million in 2025, then tumbled by 83.92% to $17.8 million in 2026.
- The last three Cash from Financing Activities figures came in at $17.8 million (Q1 2026), $110.9 million (Q4 2025), and -$317000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | -144.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | -433.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 3.76 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Personalis | 1.05 Bn | 819.64 Mn | 281,000.00 | 17.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.83 Mn |
| Mar 31, 2026 | 17.83 Mn |
| Dec 31, 2025 | 110.90 Mn |
| Dec 31, 2025 | 110.90 Mn |
| Sep 30, 2025 | -317,000.00 |
| Sep 30, 2025 | -317,000.00 |
| Jun 30, 2025 | -327,000.00 |
| Jun 30, 2025 | -327,000.00 |
| Mar 31, 2025 | 20.09 Mn |
| Mar 31, 2025 | 20.09 Mn |
| Dec 31, 2024 | 49.60 Mn |
| Dec 31, 2024 | 49.60 Mn |
| Sep 30, 2024 | 62.43 Mn |
| Sep 30, 2024 | 62.43 Mn |
| Jun 30, 2024 | 1.52 Mn |
| Jun 30, 2024 | 1.52 Mn |
| Mar 31, 2024 | 1.13 Mn |
| Mar 31, 2024 | 1.13 Mn |
| Dec 31, 2023 | 9.82 Mn |
| Dec 31, 2023 | 9.82 Mn |